| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Revenue | $130K | -68.3% |
| R&D Expense | $195K | -54.9% |
| SG&A Expense | $518K | -43.0% |
| Operating Income | -$583K | +37.4% |
| Net Income | -$695K | +81.3% |
| EPS (Basic) | -$0.02 | +95.2% |
| EPS (Diluted) | -$0.02 | +95.2% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26K | -79.6% |
| Current Assets | $31K | -86.0% |
| Total Assets | $31K | -93.7% |
| Current Liabilities | $2.5M | -0.2% |
| Stockholders' Equity | -$2.5M | -22.9% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$244K | -117.1% |
| Investing Cash Flow | $113K | +359.4% |
| Financing Cash Flow | $28K | -72.5% |